Significance and prognostic impact of co-morbidity in head and neck cancer

Journal of Cancer Research and Therapeutics

Volumn 5, Issue 3, 2009, Pages 145-147

  Kazi, Rehan ^a   Nutting, Chris M ^a   Rhys Evans, Peter ^a   Harrington, Kevin J ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE FREE INTERVAL; EDITORIAL; HEAD AND NECK CANCER; MEDICAL RECORD; PROGNOSIS; TUMOR CLASSIFICATION;

COMORBIDITY; HEAD AND NECK NEOPLASMS; HUMANS; PROGNOSIS;

EID: 70350291582     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.57117     Document Type: Editorial

References (24)

1. Yung KC, Piccirillo JF. The Incidence and Impact of Co-morbidity Diagnosed After the Onset of Head and Neck Cancer. Arch Otolaryngol Head Neck Surg 2008;134:1045-1049
2. Piccirillo J. The impact of co-morbidity in head and neck cancer. J Registry Manage 2001;28:172-176
3. Piccirillo JF. Importance of co-morbidity in head and neck cancer. Laryngoscope 2000;110:593-602.
4. Satariano WA. Comorbidities and cancer. In: Hunter CP, Johnson KA, Muss HB, eds. Cancer in the Elderly. New York, NY: Marcel Dekker; 2000. p. 477-499
5. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001;285:885-892
6. Charlson ME, Feinstein AR. A new clinical index of growth rate in the staging of breast cancer. Am J Med 1980;69:527-536
7. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatric Soc 1968;16:622-626
8. Covinsky KE, Kahana E, Kahana B, Kercher K, Schumacher JG, Justice AC. History and mobility exam index to identify community-dwelling elderly persons at risk of falling. J Gerontol A Biol Sci Med Sci 2001;56A:M253-9.
9. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness in burden in geropsychiatric practice and research: Application of the cumulative illness rating scale. Psychiatry Res 1991;41:237-248
10. Kahn KL, Park RE, Brook RH, Chassin MR, Kosecoff J, Fink A, et al. The effect of comorbidity on appropriateness ratings for two gastrointestinal procedures. J Clin Epidemiol1988;41:115-122
11. Bang D, Piccirillo JF. The Adult Co-morbidity Evaluation-27 (ACE-27) test: a new co-morbidity index for patients with cancer. Annual meeting of the American Society of Clinical Oncology. May 20,2000.
12. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a co-morbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-1267
13. Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998;20:1-7.
14. Pugliano FA, Piccirillo JF, Zequeira MR, Fredrickson JM, Perez CA, Simpson JR. Clinical-severity staging system for oral cavity cancer: five-year survival rates. Otolaryngol Head Neck Surg 1999;120:38-45.
15. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR. New clinical severity staging system for cancer of the larynx. Five-year survival rates. Ann Otol Rhinol Laryngol 1994;103:83-92.
16. Pugliano FA, Piccirillo JF, Zequeira MR, Emami B, Perez CA, Simpson JR, et al. Clinical-severity staging system for oropharyngeal cancer: five-year survival rates. Arch Otolaryngol Head Neck Surg 1997;123:1118-1124
17. Piccirillo JF. Impact of comorbidity and symptoms on the prognosis of patients with oral carcinoma. Arch Otolaryngol Head Neck Surg 2000;126:1086-1088
18. Ribeiro KC, Kowalski LP, Latorre MR. Impact of comorbidity, symptoms, and patients. characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000;126:1079-1085
19. Neel HB 3rd, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1985;94:529-537
20. Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998;21:105-113
21. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum, I: development of two new systems of staging. Arch Intern Med 1975;135:1441-1453
22. Satariano WA. Co-morbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. J Gerontol 1992;47:24-31.
23. Peipert JF, Wells CK, Schwartz PE, Feinstein AR. Prognostic value of clinical variables in invasive cervical cancer. Obstet Gynecol 1994;84:746-751
24. Piccirillo JF, Feinstein AR. Clinical symptoms and co-morbidity: significance for the prognostic classification of cancer. Cancer 1996;77:834-842